Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texting patients after ER visits may cut down on repeat trips

NCT ID NCT07185828

Recruiting now Knowledge-focused Sponsor: Geisinger Clinic Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether sending text messages and updating discharge paperwork can steer low-acuity ER patients toward primary care or an online triage tool instead of returning to the ER. About 8,286 adults who visited a Geisinger ER for non-urgent issues will be randomly assigned to receive these nudges or standard care. Researchers will track whether ER use drops in the 120 days after discharge.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
text messages and discharge paperwork modifications
What this could lead to
If it works, this could show a simple, low-cost way to reduce unnecessary emergency room visits by guiding patients to more appropriate care.
What could go wrong
This is a behavioral study, not a drug trial. Results may vary by patient engagement and health system, and the effect may be small or not last long.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BEHAVIOR CHANGE INTERVENTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BEHAVIOR CHANGE INTERVENTIONS EMERGENCY SERVICE, HOSPITAL

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Geisinger

    RECRUITING

    Danville, Pennsylvania, 17822, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.